Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
New England Journal of Medicine · 20.02.2025 · 392 (8) · 748-762
DOI: 10.1056/nejmoa2409804 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 20.02.2025. Verfasst von Jennifer R Brown und 21 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Benzamides, Leukemia, Lymphocytic, Chronic, B-Cell, Pyrazines. Die Arbeit wurde bisher 144-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dana-Farber Cancer Institute, Boston.
- Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
- Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.
- Maria Sklodowska-Curie National Institute of Oncology, Kraków, Poland.
- University of Ottawa, Ottawa.
- Medical University of Lublin, Lublin, Poland.
ORCID-Profile: Jennifer R Brown, John F Seymour, Martin Šimkovič
Förderung
- AstraZeneca
Zitieren
APA
Brown, J. R., Seymour, J. F., Jurczak, W., Aw, A., Wach, M., Illes, A., Tedeschi, A., Owen, C., Skarbnik, A., Lysak, D., Eom, K. S., Šimkovič, M., Pavlovsky, M. A., Kater, A. P., Eichhorst, B., Miller, K., Munugalavadla, V., Yu, T., de Borja, M., …, & AMPLIFY Investigators (2025). Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. New England Journal of Medicine, 392(8), 748-762. https://doi.org/10.1056/nejmoa2409804
Vancouver
Brown JR, Seymour JF, Jurczak W, Aw A, Wach M, Illes A, et al. Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. New England Journal of Medicine. 2025;392(8):748-762. doi:10.1056/nejmoa2409804
BibTeX
@article{Brown2025,
author = {Brown, Jennifer R and Seymour, John F and Jurczak, Wojciech and Aw, Andrew and Wach, Malgorzata and Illes, Arpad and Tedeschi, Alessandra and Owen, Carolyn and Skarbnik, Alan and Lysak, Daniel and Eom, Ki-Seong and Šimkovič, Martin and Pavlovsky, Miguel Arturo and Kater, Arnon Philip and Eichhorst, Barbara and Miller, Kara and Munugalavadla, Veerendra and Yu, Ting and de Borja, Marianne and Ghia, Paolo and AMPLIFY investigators, AMPLIFY investigators and AMPLIFY Investigators, AMPLIFY Investigators},
title = {Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {8},
pages = {748--762},
doi = {10.1056/nejmoa2409804}
}
EUVIMED